Press Releases from Avail Clinical Research (2 total)
New Phase 3 Irritable Bowel Syndrome (IBS) Clinical Trial Now Enrolling at Avail …
Avail Clinical Research is now enrolling for an Irritable Bowel Syndrome Clinical Trial in Florida. To get started, visit Avail Clinical Research or call us directly at (386) 310-1334.
Irritable bowel syndrome (IBS) is a functional gastrointestinal (GI) disorder that is characterized by symptoms of abdominal discomfort or pain associated with altered bowel habits (Drossman, 2006). The 4 main forms of IBS are characterized by bowel habits, and are chronic or…
SNUS and Tobacco Research Study | Avail Clinical Research
DeLand, Florida – February 6, 2010 – Avail Clinical Research, an Accel Research Company, located near Orlando, Florida, has recently announced the beginning of a clinical research study for people who regularly consume tobacco products such as: SNUS, snuff, chewing tobacco, dip, and other oral tobaccos.
“We are pleased to begin the screening evaluation process for our upcoming research study to test investigational treatments that may help us all understand the…
